METTL3 is associated with the occurrence and maintenance of acute myeloid leukemia (AML), so one study has explored whether STM2457, as a small molecule specific inhibitor of METTL3 enzyme, targeting METTL3 enzyme activity has anti-leukemia therapeutic potential. The gene discussed is METTL3; the disease is acute myeloid leukemia.